CUSIP: 14888D208
What is CUSIP 14888D208?
CUSIP 14888D208 identifies CBIO - GYRE THERAPEUTICS INC COM - Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 14888D208:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$170 | 0 | |
| 2025 Q1 | 22 | $170 | -$12 | $7.73 | 1 |
| 2024 Q4 | 15 | $182 | +$182 | $12.13 | 1 |
| 2024 Q1 | 0 | $0 | -$1,696 | 0 | |
| 2023 Q4 | 66 | $1,696 | -$1,032,317 | $25.70 | 1 |
| 2023 Q3 | 2,152,048 | $1,036,147 | -$45,056 | $0.48 | 30 |
| 2023 Q2 | 2,270,207 | $796,159 | -$255,684 | $0.35 | 28 |
| 2023 Q1 | 3,328,636 | $684,423 | -$835,975 | $0.21 | 34 |
| 2022 Q4 | 4,992,588 | $2,631,234 | -$1,437,511 | $0.53 | 31 |
| 2022 Q3 | 7,733,424 | $3,895,270 | -$1,607,804 | $0.50 | 32 |
| 2022 Q2 | 7,902,121 | $14,060,954 | -$492,010 | $1.78 | 37 |
| 2022 Q1 | 9,682,236 | $6,386,385 | -$4,241,788 | $0.66 | 41 |
| 2021 Q4 | 15,047,779 | $13,749,621 | -$26,696,387 | $0.91 | 49 |
| 2021 Q3 | 18,384,148 | $75,679,091 | -$7,469,679 | $4.11 | 64 |
| 2021 Q2 | 20,239,213 | $87,684,006 | -$10,728,031 | $4.33 | 68 |
| 2021 Q1 | 22,416,003 | $112,982,425 | +$39,424,088 | $5.04 | 87 |
| 2020 Q4 | 14,368,034 | $90,682,601 | -$1,142,136 | $6.31 | 79 |
| 2020 Q3 | 14,095,053 | $60,614,190 | -$221,255 | $4.30 | 76 |
| 2020 Q2 | 13,930,776 | $81,771,833 | +$19,138,343 | $5.87 | 79 |
| 2020 Q1 | 10,754,400 | $46,999,275 | +$11,408,286 | $4.37 | 45 |
| 2019 Q4 | 7,552,923 | $51,432,429 | +$1,256,127 | $6.81 | 45 |
| 2019 Q3 | 7,443,807 | $36,545,957 | -$820,041 | $4.91 | 40 |
| 2019 Q2 | 7,496,676 | $55,311,443 | -$5,216,474 | $7.37 | 47 |
| 2019 Q1 | 8,110,818 | $65,772,486 | +$5,313,231 | $8.11 | 60 |
| 2018 Q4 | 7,439,971 | $58,705,892 | -$5,019,285 | $7.89 | 63 |
| 2018 Q3 | 7,865,370 | $84,773,193 | -$4,283,725 | $10.78 | 67 |
| 2018 Q2 | 8,058,576 | $94,038,622 | -$47,610,810 | $11.67 | 69 |
| 2018 Q1 | 8,524,857 | $219,938,000 | +$155,050,361 | $25.80 | 51 |
| 2017 Q4 | 2,575,595 | $35,132,000 | +$18,352,374 | $13.64 | 26 |
| 2017 Q3 | 1,254,597 | $6,339,000 | +$539,581 | $5.04 | 10 |
| 2017 Q2 | 1,179,880 | $5,484,000 | +$4,495,339 | $4.65 | 16 |
| 2017 Q1 | 182,568 | $1,721,000 | +$1,721,000 | $9.43 | 10 |
| 2016 Q4 | 899 | $1,000 | +$1,000 | $1.11 | 1 |